comparemela.com

Latest Breaking News On - Astellas pharma ltd - Page 2 : comparemela.com

Astellas and Bayer announce management changes

Two Big Pharma companies have announced management changes in 2023: Astellas will have a new President and CEO and Bayer AG, a new CEO.

United kingdomBill andersonKenji yasukawaAdam pearsonClaus zielerNaoki okamuraNorbert winkeljohannWerner baumannBayer agAstellas pharma ltdMassachusetts institute of technologyInternational marketsAstellas groupAstellas pharma europe ltdYamanouchi groupAstellas pharma inc

Astellas Announces Change of President and CEO and Management Structure

/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that at a meeting of its Board of.

United statesUnited kingdomAstellas pharma europeKenji yasukawaAdam pearsonHideki shimaNaoki okamuraSenmu tantou yakuinCatherine levittFukusyacho tantou yakuinYoshitsugu shitakaClaus zielerAstellas pharmaKatsuyoshi sugitaYukio matsuiMinoru kikuoka

NICE Recommends Astellas EVRENZO▼™ (roxadustat) For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease

NICE Recommends Astellas’ EVRENZO▼™ (roxadustat) For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease EVRENZOTM (roxadustat) is the first hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor to be recommended by NICE1Over 75,000 adults in England and Wales living with.

United kingdomOrenburgskaya oblastUnited statesBelgorodskaya oblastNew zealandSouth africaSouth koreaNorthern irelandGreat britainKenji yasukawaAndrea brownResearch partnershipsKidney internationalRenal association clinical practice guidelineAstellas pharma ltdPr market research

vimarsana © 2020. All Rights Reserved.